P53 tumor-suppressor gene and cyclic adenosine-monophosphate in breast and esophageal cancer are regulated through high-concentration of epidermal growth-factor.
To reveal the molecular mechanism of the growth-inhibitory effects of high concentrations of EGF, accumulations of p53 protein and p21ras expression in MX-1 and UM-1 breast cancer and ES-4 esophageal cancer transplanted into nude mice were investigated after local injections of 2 mug of EGF or 2 mug of TGF-beta. The accumulation of p53 protein and expression of p21ras were determined by using the methods of Western immunoblotting and p53 mutant selective quantitative ELISA assay. p53 mutation was investigated by using the PCR analysis and DNA sequencing. Contents of intra-cellular-cAMP of these tumors were also determined by radioimmunoassay. Results showed that the high concentration of EGF induced the accumulations not only of wild type p53 protein, but also of mutant p53 protein in these tumors growth-inhibited by EGF. In ES-4 esophageal cancer, 2 mug of EGF induced the up-regulation of p53 and the down-regulation of p21ras. On the contrary, 2 mug of TGF-beta induced the down-regulation of p53 and the up-regulation of p21ras in UM-1 human breast cancer. The point mutation of p53 gene was found at codon 181 contained C to T transversions (Amino acid switch: Arg --> Cys) in ES-4 esophageal cancer. The accumulations of p53 proteins were also associated with the down regulated intra-cellular-cAMP induced by high concentrations of EGF. These results indicate that p53 gene and ras gene are involved in the signal pathway of EGF and that the p53 gene may have some important role as a negative growth factor by suppressing ras oncogene in the mechanism of tumor growth inhibition through the high concentration of EGF.